EMVision Medical Devices (ASX:EMV) started an aeromedical feasibility and usability study of its first responder brain scanner device, according to a Thursday filing with the Australian bourse.
The study, designed to determine if the device's aeromedical workflow is suitable for use in an emergency aeromedical stroke response, is expected to be completed in the first quarter of fiscal 2026, the filing said.
The company's shares were down 1% in recent Thursday trade.